Improving rectal cancer diagnosis and treatment
Part of Cancer, Digestive system clinical trials.
This trial reviews MRI scans and pathology reports from people with rectal cancer to improve how the disease is diagnosed and treated. It may help doctors better plan care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years or older.
- You must have rectal cancer confirmed by a biopsy or surgery.
- Your hospital must be able to share your MRI scans and reports for review.
- You must not have cancer that has spread too far to be removed.
- You must not be receiving palliative care (treatment to relieve symptoms, not cure).
- Your cancer must be a common type of rectal cancer (adenocarcinoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
This study looks back at medical records to compare how MRI scans and lab tests describe tumour deposits (small clusters of cancer cells) in people with rectal cancer. It aims to improve how doctors report these deposits in the future, which may help guide treatment decisions.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
Hear when a new GI Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.